Results 161 to 170 of about 58,092 (289)

Early and Sustained Improvements in Sense of Smell With Tezepelumab Treatment in Patients With Chronic Rhinosinusitis With Nasal Polyps (WAYPOINT)

open access: yesInternational Forum of Allergy &Rhinology, Volume 16, Issue 5, Page 484-494, May 2026.
ABSTRACT Background Loss of smell is a principal symptom of chronic rhinosinusitis with nasal polyps (CRSwNP), affecting health‐related quality of life and posing a safety hazard. Methods WAYPOINT (NCT04851964), a phase 3, multicenter trial in adults with uncontrolled CRSwNP, randomized patients 1:1 to receive tezepelumab 210 mg or placebo ...
Joaquim Mullol   +14 more
wiley   +1 more source

COX5A induces M2 macrophage polarization in chronic rhinosinusitis with nasal polyps through ROS generation. [PDF]

open access: yesInflamm Res
Wang J   +9 more
europepmc   +1 more source

Functional Endoscopic Sinus Surgery in Adults With CRSwNP Treated With Mepolizumab: Airway Physiology Outcomes From a Randomised Controlled Trial

open access: yes
Clinical &Experimental Allergy, EarlyView.
Jens Tidemandsen   +7 more
wiley   +1 more source

Association of Increased Nasal Fluids-Serum Concordance of Protein Profile with Prognosis in Nasal Polyps. [PDF]

open access: yesJ Inflamm Res
Hou Y   +12 more
europepmc   +1 more source

Multiple Myeloma Presenting as Lower Gastrointestinal Bleeding: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT Multiple myeloma (MM) is a malignant hematologic neoplasm that primarily affects the bone marrow and can invade other organs, leading to diverse clinical manifestations. Presentation with gastrointestinal bleeding as the initial symptom is exceptionally rare.
Ahmed Arabi   +4 more
wiley   +1 more source

Natural Killer Cell Dysfunction Causes Eosinophil Accumulation in Chronic Rhinosinusitis With Nasal Polyps. [PDF]

open access: yesClin Transl Allergy
Sato Y   +9 more
europepmc   +1 more source

Chronic rhinosinusitis during immune checkpoint inhibition in melanoma patients

open access: yes
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Yenny Angela   +3 more
wiley   +1 more source

Less Can Be Enough: Sustained Remission of Pediatric Eosinophilic Esophagitis With Low‐Frequency Dupilumab

open access: yesClinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT Eosinophilic esophagitis (EoE) is a chronic, immune‐mediated disease requiring long‐term therapy. Dupilumab, an interleukin‐4 and interleukin‐13 receptor antagonist, is approved for EoE at a weekly 300 mg dosing regimen. However, data on reduced‐frequency dosing, especially in pediatric patients, remain limited.
Giovanni Scatigna   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy